Find your path to Kathryn
157 people in our graph share verified history with Kathryn — schools, employers, funds. One of them is your warm intro.
Joe HayesunlockedKathryn: together at Pathos (2023)
×7Kathryn: together at AbbVie
×4Kathryn: together at Loyola University Chicago
Clinical Development Executive at GABA Therapeutics
Intro paths
→
In turn, Kathryn can intro founders to GABA Therapeutics's investors below.
GABA Therapeutics's investors · 1
Experience
- Skyhawk TherapeuticsSenior Vice President of Clinical Operationscurrent2026 — presentWaltham, MA
- GABA Therapeutics, IncAdvisorcurrent2026 — present
- GABA Therapeutics, IncChief Operating Officer2024 — 2026Newport Beach, CA
- The University of Chicago Graham SchoolAdjunct Instructor2019 — 2025Chicago, Illinois
- PathosSenior Vice President | Head of Clinical Operations2023Remote
- Aptinyx Inc.Senior Vice President | Clinical and CMC Operations2021 — 2023Evanston, IL
- Aptinyx Inc.Senior Vice President | Clinical Development2019 — 2021Evanston, Illinois, United States
- Levo Therapeutics, Inc.Vice President | Clinical Research | Development Operations2017 — 2018Skokie, IL
- AbbVieVice President | Clinical Program Development2016 — 2017North Chicago, IL
- Veeva SystemsVice President | Vault Clinical2015 — 2016
- Takeda PharmaceuticalsVice President | Global Clinical Operations2012 — 2015Deerfield, IL
- AbbottDirector | Development Operations Transformation Program Management Office2012Abbott Park IL
- AbbottDirector | Clinical Field Operations and Document Management2009 — 2012
- AbbottDirector | Clinical Program Management - All Therapeutic Areas and Trial Specialty2008 — 2009
- AbbottDirector | Clinical Program Management - Infectious Diseases, CNS and Neonatology2007 — 2008
- AbbottHIV | Virology Clinical Development1994 — 2007
Skills & more
NeuroscienceWorking with InvestorsMentoringFinancial PlanningHIV/AIDSNew Drug Application (NDA)Quality SystemHigher Education TeachingPhase OnePhase IIIRegulatory ApprovalsPhase II
+12 more
Development OperationsPublic SpeakingPresentation SkillsOperational Planning21 CFRPharmaceuticalsOutsourcingBusiness Process ImprovementTechnical Sales SupportTrial Master File (TMF)Electronic Trial Master File (eTMF)Online TeachingFrom Kathryn's professional profile.
Frequently asked questions
- Who is Kathryn King?
- Clinical Development Executive at GABA Therapeutics
- Where does Kathryn King work?
- Kathryn King is Clinical Development Executive at GABA Therapeutics.
- Where did Kathryn King go to school?
- Kathryn King studied at University of Notre Dame (BS, Biochemistry); Loyola University Chicago (PhD, Philosophy - Ethics); Loyola University Chicago (MA, Health Care Ethics).
Same school
Also attended University of Notre Dame438
Doug GrohAdvisor at CincyTechMimi DunnSenior Investment Analyst at Catalyst Health VenturesJim HuntGeneral Partner at Lavrock VenturesTristan HuntPartner at Averin CapitalJoanne IshamSenior Advisory Board at IronGate Capital AdvisorsAlex FlorAssociate at TCV
+ 432 more
Also attended Loyola University Chicago76
Jennifer CarolanCo-founder at Reach CapitalSri PedduInvestor at Powerhouse VenturesLijuan WangSenior Accountant at Red Cell IncubationChloe BierutCommunity & Events Manager at Energize VenturesKyle WelbornCofounder & General Partner at Cultivation CapitalClaire KnowltonMarketing Associate at F-Prime Capital Partners
+ 70 more
Shared employers
Also worked at Skyhawk Therapeutics3
Also worked at GABA Therapeutics, Inc1
Also worked at Aptinyx Inc.6
Patrick EnrightManaging Director at Longitude CapitalSandip AgarwalaManaging Director at Blue Owl CapitalJuan EstupinanExecutive Officer, Director at Vestaron, Inc.Heather ReadCo-Founder + Science Advisor at ElemindPatrick EnrightGeneral Partner at Longitude EastPatrick EnrightGeneral Partner at Longitude Prime
